CNMD - CONMED Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
932,675
859,634
796,392
763,520
719,168
Cost of revenue
417,280
390,524
365,351
355,190
337,466
Gross profit
515,395
469,110
431,041
408,330
381,702
Operating expenses
Research development
43,737
42,188
32,307
32,254
27,436
Selling general and administrative
394,601
355,617
351,799
338,400
303,091
Total operating expenses
438,338
397,805
384,106
370,654
330,527
Operating income or loss
77,057
71,305
46,935
37,676
51,175
Interest expense
37,911
20,652
18,203
15,359
6,031
Total other income/expenses net
-
-
-
-2,942
0
Income before tax
34,279
50,653
28,732
19,375
45,144
Income tax expense
4,940
9,799
-26,755
4,711
14,646
Income from continuing operations
29,339
40,854
55,487
14,664
30,498
Net income
29,339
40,854
55,487
14,664
30,498
Net income available to common shareholders
29,339
40,854
55,487
14,664
30,498
Reported EPS
Basic
-
1.45
1.99
0.53
1.10
Diluted
-
1.41
1.97
0.52
1.09
Weighted average shares outstanding
Basic
-
28,118
27,939
27,804
27,653
Diluted
-
28,890
28,171
27,964
27,858
EBITDA
-
133,108
105,483
90,043
95,054